Systematic review of efficacy and safety of retrievable inferior vena caval filters

Affiliations

¹ Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY, USA; Yale/YNHH Center for Outcomes Research & Evaluation (CORE), New Haven, CT, USA; Cardiovascular Research Foundation (CRF), New York, NY, USA. Electronic address: bb2813@cumc.columbia.edu.
² Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain.
³ Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY, USA; Cardiovascular Research Foundation (CRF), New York, NY, USA.
⁴ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
⁵ Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada; Division of Hematology & Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada.
⁶ Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
⁷ Yale/YNHH Center for Outcomes Research & Evaluation (CORE), New Haven, CT, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.

Behnood Bikdeli et al. Thromb Res. 2018 May.

. 2018 May:165:79-82.

doi: 10.1016/j.thromres.2018.03.014. Epub 2018 Mar 17.

¹ Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY, USA; Yale/YNHH Center for Outcomes Research & Evaluation (CORE), New Haven, CT, USA; Cardiovascular Research Foundation (CRF), New York, NY, USA. Electronic address: bb2813@cumc.columbia.edu.
² Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain.
³ Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY, USA; Cardiovascular Research Foundation (CRF), New York, NY, USA.
⁴ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
⁵ Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada; Division of Hematology & Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada.
⁶ Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
⁷ Yale/YNHH Center for Outcomes Research & Evaluation (CORE), New Haven, CT, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.

No abstract available

Keywords: Pulmonary embolism; Retrievable; Vena cava filter; Venous thromboembolism.

Figures

1. Kaufman JA, Kinney TB, Streiff MB, et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol. 2006;17(3):449–459. - PubMed
1. Bikdeli B, Wang Y, Minges KE, et al. Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010. J Am Coll Cardiol. 2016;67(9):1027–1035. - PMC - PubMed
1. Bikdeli B, Ross JS, Krumholz HM. Data Desert for Inferior Vena Caval Filters: Limited Evidence, Supervision, and Research. JAMA Cardiol. 2016 - PubMed
1. Bikdeli B, Chatterjee S, Desai NR, et al. Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2017;70(13):1587–1597. - PMC - PubMed
1. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830. - PubMed